This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Ovarian dysfunction: estrogen excess
E4_ODESTRO
hyperestrogenism: ['Abnormally high level of estrogen. [ NICHD NCI ]']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
50 |
4. Check minimum number of eventsNone |
50 |
5. Include endpointsNone |
50 |
6. Filter based on genotype QC (FinnGen only) |
50 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E28
- Name in latin
- Hypersecretio oestrogenorum
Similar endpoints
↥List of similar endpoints to
Ovarian dysfunction: estrogen excess
based on the number of shared cases.
Similar with more cases:
- Ovarian dysfunction
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 403 | 403 | - |
| Only index persons | 320 | 320 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | - |
| Only index persons | 0.01 | 0.01 | - |
| Median age at first event (years) | |||
| Whole population | - | 35.28 | - |
| Only index persons | - | 31.34 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 50 | 50 | - |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | - |
| Median age at first event (years) | 29.52 | 29.52 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
5
0
+∞
5.29
1.2
0.0
nmol/l
39.4
—
—
5
0
(3020682) Albumin/Creatinine [Ratio] in Urine
18
75
3.19
3.46
2.8
3.5
mg/mmol
0.5
8.4
—
6
44
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
16
64
3.21
3.27
1.3
3.5
ng/l
271.3
989.5
—
9
54
(3012516) Albumin [Mass/volume] in Urine
17
74
2.97
2.99
2.6
2.8
mg/l
5.7
39.7
—
7
43
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
12
5.51
2.48
2.3
2.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
44
347
3.23
2.30
6.5
4.2
mmol/mol
38.9
38.0
0.23
39
332
(3009508) Creatinine [Moles/volume] in Urine
18
94
2.43
2.15
2.4
2.5
mmol/l
7.9
6.9
0.31
12
78
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
42
0.00
1.61
0.0
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
26
176
1.99
1.55
2.2
1.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
38
0.00
1.41
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
39
0.00
1.41
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
39
0.00
1.41
0.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
39
0.00
1.41
0.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
39
0.00
1.41
0.0
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
9
44
2.27
1.35
1.3
1.7
s
25.6
29.7
—
9
44
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
45
386
2.65
1.34
9.0
9.1
ml/min/173m2
93.6
90.0
0.57
38
304
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
36
0.00
1.19
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
36
0.00
1.19
0.0
1.3
—
—
—
0
0
(4010399)
7
31
2.46
1.16
1.1
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
19
127
1.80
1.10
1.8
2.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
48
2.06
1.08
1.7
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
20
137
1.77
1.07
1.7
2.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
16
103
1.81
1.04
1.6
2.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
38
316
1.84
1.00
3.6
3.7
—
—
—
0
0
(3019225) pH of Specimen
6
27
2.38
0.97
2.5
5.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
17
114
1.74
0.96
1.8
2.8
e6/l
11.0
46.5
1.23
11
84
(3030467) Casts [#/volume] in Urine by Automated count
15
97
1.78
0.95
1.6
2.5
e6/l
0.0
0.3
—
9
67
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7
121
0.51
0.94
2.0
1.7
—
—
—
0
0
(4035726)
6
30
2.13
0.90
2.0
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
20
143
1.66
0.89
1.9
3.4
e6/l
3.2
110.1
1.74
13
91
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
18
127
1.65
0.84
2.4
2.8
u/l
22.6
26.2
0.92
18
119
(42870588) Differential panel, method unspecified - Blood
17
120
1.63
0.78
2.1
4.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
39
1.92
0.76
2.9
7.0
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
5
25
2.11
0.75
1.8
1.9
u/ml
23.7
61.9
—
5
25
(46235355) HIV 1 and 2 tests - Meaningful Use set
10
150
0.58
0.73
2.4
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
6
104
0.52
0.72
2.3
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
20
150
1.56
0.71
4.5
3.8
g/l
35.8
36.6
0.32
20
142
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
27
1.94
0.70
1.0
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
20
151
1.54
0.69
2.2
1.8
pmol/l
96.8
98.6
—
10
83
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
28
1.87
0.68
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
19
0.00
0.62
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
37
1.70
0.58
1.3
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
45
1.64
0.52
1.1
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
23
188
1.41
0.51
2.3
4.5
%
0.5
0.6
0.66
18
171
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
13
95
1.50
0.50
1.8
1.8
mg/l
0.3
0.7
—
8
69
(40768797) Stomach Pathology biopsy report
7
48
1.53
0.49
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
44
410
1.61
0.48
13.9
11.3
%
40.2
39.5
0.64
38
327
(3013512) EKG study
12
88
1.48
0.45
2.4
2.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
8
57
1.48
0.45
1.1
1.5
—
—
—
0
0
(3000492) Spirometry study
5
31
1.68
0.44
1.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
58
1.45
0.44
2.0
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
30
262
1.36
0.42
3.4
2.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
0
17
0.00
0.41
0.0
3.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
18
0.00
0.40
0.0
1.4
—
103.4
—
0
18
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
70
1.35
0.39
2.1
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
36
1.43
0.39
1.6
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
11
82
1.44
0.38
1.3
1.3
iu/ml
15.8
39.9
—
5
26
(3007164) IgA [Mass/volume] in Serum or Plasma
13
101
1.39
0.36
1.2
1.5
g/l
3.0
2.6
—
6
64
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
6
44
1.41
0.36
2.8
3.0
umol/l
4.3
6.9
—
6
35
(3041096) Erythrocytes [Presence] in Urine by Automated
16
130
1.34
0.34
3.6
2.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
105
0.72
0.33
2.8
2.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
7
54
1.34
0.32
2.6
1.9
mmol/l
0.8
0.8
—
7
49
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7
54
1.34
0.32
2.1
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
17
143
1.29
0.28
2.0
1.5
—
—
—
0
0
(3015736) pH of Urine
20
172
1.27
0.28
2.7
3.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
37
1.39
0.24
1.6
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
5
42
1.21
0.22
1.2
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
1.3
—
0
6
(4094501)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
3.7
—
0
6
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
13
0.00
0.21
0.0
2.5
—
4.2
—
0
8
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
14
0.00
0.20
0.0
2.4
—
203.6
—
0
14
(40768443) Skin Pathology biopsy report
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
6
51
1.20
0.20
1.3
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
57
1.26
0.19
1.9
2.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
66
0.73
0.18
1.8
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
9
77
1.21
0.17
3.8
4.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
19
171
1.18
0.15
4.1
3.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
8
94
0.82
0.15
4.0
3.5
—
1.0
—
0
11
(3018418) pH of Serum or Plasma
13
114
1.19
0.13
8.7
3.2
—
7.4
—
0
17
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
115
0.84
0.12
3.2
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
43
1.18
0.10
1.6
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
14
126
1.15
0.10
1.4
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
46
1.10
0.10
1.6
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
7
66
1.07
0.08
1.3
2.0
mosm/kgh2o
567.0
556.9
—
7
57
(3000850) Epithelial cells [#/volume] in Urine
8
75
1.08
0.08
1.6
2.5
e6/l
4.4
6.2
—
8
68
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
22
207
1.11
0.08
5.0
4.9
umol/l
7.3
9.2
1.63
22
194
(3009261) Glucose [Presence] in Urine by Test strip
23
217
1.11
0.08
3.7
3.3
estimate
0.0
0.0
—
5
42
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
80
0.85
0.08
1.3
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
8
92
0.84
0.07
3.1
3.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
13
119
1.12
0.06
2.5
4.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
40
392
1.10
0.03
15.7
13.8
g/l
329.3
331.6
0.63
40
392
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
10
94
1.08
0.01
2.1
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
12
114
1.07
0.01
5.1
3.6
estimate
0.0
0.0
—
5
42
(3003694) ABO and Rh group [Type] in Blood
13
136
0.94
0.01
1.8
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
21
204
1.05
0.00
3.8
3.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
37
375
0.95
0.00
4.1
3.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
17
174
0.97
0.00
1.8
2.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
11
112
0.98
0.00
2.5
4.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
13
132
0.98
0.00
2.2
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
6
0.00
0.00
0.0
1.5
—
91.7
—
0
6
(4198724)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
6.3
—
0
5
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
112.1
—
0
7
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
7
0.00
0.00
0.0
2.3
—
64.4
—
0
7
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
62
0.96
0.00
1.3
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
0
7
0.00
0.00
0.0
2.4
—
4.7
—
0
7
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
164.6
—
0
5
(3034770) Mitochondria Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
108.9
—
0
5
(4306422)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
7
0.00
0.00
0.0
2.4
—
10.7
—
0
7
(3005570) Glucose [Moles/volume] in Urine
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
7
0.00
0.00
0.0
2.3
—
5.8
—
0
7
(3052851) Hemolysis interference index of Serum or Plasma
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_ODESTRO and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have E4_ODESTRO.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: E4_ODESTRO – Ovarian dysfunction: estrogen excess
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data